Atom Investors’s GSK GSK Stock Holding History

Atom Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-79,152	Closed	-$3.04M	–	694
2025 Q2	$3.04M	Buy	+79,152	New	+$3.02M	0.27%	105
2024 Q4	–	Sell	-7,240	Closed	-$296K	–	552
2024 Q3	$296K	Buy	+7,240	New	+$296K	0.03%	375
2024 Q2	–	Sell	-116,706	Closed	-$5M	–	555
2024 Q1	$5M	Buy	116,706 +106,160	+1,007%	+$4.38M	0.62%	36
2023 Q4	$391K	Buy	+10,546	New	+$379K	0.07%	316

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Atom Investors's GSK Position: Q3 2025 in Review

Atom Investors sold out of GSK (GSK) in Q3 2025, closing a stake of 79,152 shares — an estimated $3.04M sold.

Atom Investors first reported a position in GSK in Q4 2023 and held it in 4 quarters. The position peaked at $5M in Q1 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Atom Investors reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Atom Investors sold 79,152 GSK shares in Q3 2025, an estimated $3.04M.
Atom Investors first reported a position in GSK in Q4 2023 and held it in 4 quarters.
Atom Investors's GSK position peaked at $5M in Q1 2024.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.